Study Details and Findings

Research⁣ led by Daniele Baccarelli, Professor and⁣ Chair of Environmental Health Sciences at Columbia University Mailman School‍ of Public Health,⁤ revealed an association between acetaminophen exposure during pregnancy and an increased risk of neurodevelopmental⁤ disorders in children. The study, published in September 2024,⁢ analyzed data from a large cohort and found the‍ association was strongest ⁣when acetaminophen⁣ was ⁤taken for four ⁤weeks or longer.

The study builds on previous research suggesting potential risks associated with acetaminophen use during pregnancy. High fever, which acetaminophen is frequently enough used to treat, can also harm the⁢ developing fetus, raising the risk of neural‍ tube defects and preterm birth. The researchers emphasize the need for ⁣”judicious acetaminophen use -‍ lowest effective dose, shortest duration – under medical guidance, tailored to individual risk-benefit ⁣assessments, rather than a‍ broad limitation.”

FDA Response and White House Discussions

In late September 2024, the Food and Drug Administration (FDA) announced it would issue a letter to clinicians urging caution regarding acetaminophen use in pregnancy. Baccarelli stated he discussed his study ⁢with Health ⁢and Human Services Secretary Robert F. Kennedy Jr. in the weeks leading up to the announcement. He provided the White House team with a statement highlighting his research’s findings: “evidence of an association” between prenatal acetaminophen exposure and neurodevelopmental disorders.

Baccarelli’s statement further clarified: “that ⁢association ⁣is strongest when acetaminophen is taken⁢ for four weeks or longer. Further ⁢research is needed to confirm the association ⁣and⁤ determine causality, but based on existing evidence, I believe that caution about acetaminophen use during pregnancy – especially heavy or prolonged use – is warranted.”

Potential Conflicts of Interest

Baccarelli disclosed in the research‍ paper’s “competing⁤ interests” section that he has served as an expert‍ witness for plaintiffs in legal cases involving potential links between acetaminophen use⁣ during pregnancy and neurodevelopmental disorders.This disclosure is vital⁢ to consider when evaluating the study’s findings.

research Collaboration and Funding

The study was a collaborative effort involving researchers from the University of California, Los angeles; University of ⁢Massachusetts Lowell; and Harvard T.H. Chan School of Public Health.

Funding for ⁢the research was provided by the National Cancer institute (U54CA267776), the National⁤ Institute of Environmental Health Sciences (R35ES031688), and the National⁢ Institute on ‍Aging (U01AG088684). ⁢ The NIH RePORTER database provides ⁤further details on ⁤these grants.